Page last updated: 2024-08-17

cycloserine and fosfomycin

cycloserine has been researched along with fosfomycin in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19905 (29.41)18.7374
1990's3 (17.65)18.2507
2000's5 (29.41)29.6817
2010's4 (23.53)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agouridas, C; Girodeau, JM; Le Goffic, F; Masson, M; Pineau, R1
Cheung, A; Götz, F; Herbert, S; Meehl, M1
Chung, M; Sieradzki, K; Tomasz, A1
Awuah, E; Barker, C; Brown, ED; Capretta, FA; Das, R; Gerritsma, DA; Lebert, J; Melacini, G; Pathania, R; Zlitni, S1
Campillo, NE; Guerra, A; Páez, JA1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ely, B; Johnson, RC1
Ball, P; Chopra, I1
Bertrand, KP; Moyed, HS1
Daneo-Moore, L; Kral, TA1
Grenader, A; Ulijasz, AT; Weisblum, B1
Sieradzki, K; Tomasz, A1
O'Connor, KA; Zusman, DR1
Katayama, N; Kuroiwa, H; Ono, K; Sakai, A; Sugiyama, M; Takano, H; Takio, S; Tanaka, K1
Helmann, JD; Salzberg, LI1
Bender, JK; Halbedel, S; Rismondo, J1

Reviews

2 review(s) available for cycloserine and fosfomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Transport of antibiotics into bacteria.
    Advances in microbial physiology, 1982, Volume: 23

    Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Biological Transport; Biological Transport, Active; Butylene Glycols; Cell Membrane; Cephalosporins; Chloramphenicol; Cycloserine; Energy Metabolism; Ferrous Compounds; Fosfomycin; Iron; Models, Biological; Organophosphonates; Penicillins; Peptides; Peptides, Cyclic; Peptidoglycan; Showdomycin; Streptozocin; Tetracyclines

1982

Other Studies

15 other study(ies) available for cycloserine and fosfomycin

ArticleYear
The lysine pathway as a target for a new genera of synthetic antibacterial antibiotics?
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:6

    Topics: Amino Acid Isomerases; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Carboxy-Lyases; Diaminopimelic Acid; Lysine; Racemases and Epimerases; Structure-Activity Relationship

1986
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance

2007
Role of a sodium-dependent symporter homologue in the thermosensitivity of beta-lactam antibiotic resistance and cell wall composition in Staphylococcus aureus.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; Cell Wall; DNA Transposable Elements; Hot Temperature; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Sodium; Staphylococcus aureus; Symporters

2008
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting.
    Nature chemical biology, 2009, Volume: 5, Issue:11

    Topics: Anti-Bacterial Agents; Cell Division; Chromatography, Liquid; Cycloserine; Doxorubicin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Genes, Bacterial; Genome, Bacterial; Genomics; Lipoproteins; Mass Spectrometry; Molecular Chaperones; Periplasmic Binding Proteins; Pseudomonas aeruginosa; Sulfamethoxazole; Suppression, Genetic; Trimethoprim

2009
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
Isolation of spontaneously derived mutants of Caulobacter crescentus.
    Genetics, 1977, Volume: 86, Issue:1

    Topics: Anti-Bacterial Agents; Bacteria; Cycloserine; Fosfomycin; Mutation; Penicillinase

1977
hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis.
    Journal of bacteriology, 1983, Volume: 155, Issue:2

    Topics: Ampicillin; Chromosome Mapping; Chromosomes, Bacterial; Conjugation, Genetic; Cycloserine; Diaminopimelic Acid; Escherichia coli; Fosfomycin; Genes, Bacterial; Mutation; Penicillin Resistance; Peptidoglycan; Spheroplasts

1983
Effects of cell wall inhibitors on cell division in Streptococcus mutans.
    Infection and immunity, 1983, Volume: 41, Issue:1

    Topics: Anti-Bacterial Agents; Bacteriolysis; Cell Division; Cell Wall; Chloramphenicol; Chromosomes; Cycloserine; DNA Replication; Fosfomycin; Mitomycin; Mitomycins; Penicillin G; Streptococcus mutans; Vancomycin

1983
A vancomycin-inducible lacZ reporter system in Bacillus subtilis: induction by antibiotics that inhibit cell wall synthesis and by lysozyme.
    Journal of bacteriology, 1996, Volume: 178, Issue:21

    Topics: Anti-Bacterial Agents; Bacillus subtilis; Cell Wall; Cloning, Molecular; Culture Media; Cycloserine; Endopeptidases; Fosfomycin; Genes, Reporter; Lac Operon; Lysostaphin; Muramidase; Teicoplanin; Vancomycin

1996
Suppression of beta-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A

    Topics: Anti-Bacterial Agents; beta-Alanine; beta-Lactam Resistance; Colony Count, Microbial; Cycloserine; Drug Synergism; Fosfomycin; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus

1997
Induction of beta-lactamase influences the course of development in Myxococcus xanthus.
    Journal of bacteriology, 1999, Volume: 181, Issue:20

    Topics: Ampicillin; Bacterial Proteins; beta-Lactamases; Caseins; Chemotaxis; Culture Media; Cycloserine; Enzyme Induction; Fosfomycin; Mutation; Myxococcus xanthus; Protein Hydrolysates; Signal Transduction; Spores, Bacterial; Vancomycin

1999
Effects of antibiotics that inhibit the bacterial peptidoglycan synthesis pathway on moss chloroplast division.
    Plant & cell physiology, 2003, Volume: 44, Issue:7

    Topics: Ampicillin; Anti-Bacterial Agents; Bacitracin; Bryopsida; Chloroplasts; Cycloserine; Fosfomycin; Peptidoglycan; Vancomycin

2003
An antibiotic-inducible cell wall-associated protein that protects Bacillus subtilis from autolysis.
    Journal of bacteriology, 2007, Volume: 189, Issue:13

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacillus subtilis; Bacitracin; Bacterial Proteins; Bacteriolysis; Base Sequence; Carrier Proteins; Cell Wall; Cephalosporins; Cycloserine; Drug Resistance, Bacterial; Fosfomycin; Gene Expression Regulation, Bacterial; Molecular Sequence Data; Mutation; N-Acetylmuramoyl-L-alanine Amidase; Sequence Alignment; Succinate Dehydrogenase; Time Factors; Vancomycin

2007
Suppressor Mutations Linking gpsB with the First Committed Step of Peptidoglycan Biosynthesis in Listeria monocytogenes.
    Journal of bacteriology, 2017, 01-01, Volume: 199, Issue:1

    Topics: Bacitracin; Bacterial Proteins; Cycloserine; Fosfomycin; Gene Expression Regulation, Bacterial; Listeria monocytogenes; Mutation; Peptidoglycan

2017